Phosphate restriction using a processed clay mineral reduces vascular pathologies and microalbuminuria in rats with chronic renal failure

BACKGROUND: The progression of chronic kidney disease (CKD) is associated with an increasing risk of cardiovascular morbidity and mortality due to elevated serum phosphate levels. Besides low phosphate diets and hemodialysis, oral phosphate binders are prescribed to treat hyperphosphatemia in CKD pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofrichter, Jacqueline, Sempert, Kai, Kerkhoff, Claus, Breitrück, Anne, Wasserkort, Reinhold, Mitzner, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052552/
https://www.ncbi.nlm.nih.gov/pubmed/35484519
http://dx.doi.org/10.1186/s12882-022-02743-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052552/
https://www.ncbi.nlm.nih.gov/pubmed/35484519
http://dx.doi.org/10.1186/s12882-022-02743-5

Ejemplares similares